Cargando…
Amelioration of Paget Disease of Bone After Denosumab for Osteopenia
BACKGROUND/OBJECTIVE: Denosumab is a monoclonal antibody that inhibits bone resorption and is indicated for the treatment of osteoporosis, bone metastases, and giant cell tumor of bone. We describe a woman with symptomatic Paget disease of the skull whose headaches and monostotic disease of the skul...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
American Association of Clinical Endocrinology
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10509370/ https://www.ncbi.nlm.nih.gov/pubmed/37736316 http://dx.doi.org/10.1016/j.aace.2023.05.007 |